Close

Canaccord Genuity Positive on GenMark Diagnostics (GNMK)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. GOOGL
3. CMG
4. MSFT
5. SPY
6. LRCX
7. IBM
8. INTC
9. SNAP
10. HCP


January 15, 2013 11:53 AM EST
Get Alerts GNMK Hot Sheet
Price: $24.04 --0%

Rating Summary:
    2 Buy, 6 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 12 | New: 1
Join SI Premium – FREE
Canaccord Genuity today reiterated a Buy rating on GenMark Diagnostics (NASDAQ: GNMK) and raised its price target to $14.00 (from $12.00).

"Given management's recent track record of executing, coupled with its long-term growth trajectory, we believe GNMK merits trading at the upper end of the MDx peer group P/S multiple (5x-7x)," said analyst Jeffrey Frelick.

With a strong start to the flu season, Frelick thinks GNMK should see good results from its RVP test.

For an analyst ratings summary and ratings history on GenMark Diagnostics (NASDAQ: GNMK) click here. For more ratings news on GenMark Diagnostics click here.

Shares of GenMark Diagnostics closed at $11.14 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Canaccord Genuity